tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TSE:RKV Stock Latest News

Rakovina Therapeutics Secures $2 Million for Cancer Research
Company AnnouncementsRakovina Therapeutics Secures $2 Million for Cancer Research
5m ago
RKV
Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement
PremiumPress Releases
Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement
42m ago
RKV
Rakovina Therapeutics Closes $2M in Funding Round
PremiumCompany Announcements
Rakovina Therapeutics Closes $2M in Funding Round
4d ago
RKV
Rakovina Therapeutics Provides Update on Previously Announced Private Placement
PremiumPress Releases
Rakovina Therapeutics Provides Update on Previously Announced Private Placement
4d ago
RKV
Rakovina Therapeutics Announces Second Upsizing of Private Placement
PremiumPress Releases
Rakovina Therapeutics Announces Second Upsizing of Private Placement
8d ago
RKV
Rakovina Therapeutics Surpasses Funding Goal
PremiumCompany AnnouncementsRakovina Therapeutics Surpasses Funding Goal
1M ago
RKV
Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting
PremiumPress Releases
Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting
1M ago
RKV
Rakovina Therapeutics Leverages AI for Cancer Drug Development
PremiumCompany Announcements
Rakovina Therapeutics Leverages AI for Cancer Drug Development
2M ago
RKV
Rakovina Therapeutics Announces 2024 Q1 Financial Results and Provides Corporate Update
PremiumPress Releases
Rakovina Therapeutics Announces 2024 Q1 Financial Results and Provides Corporate Update
2M ago
RKV
Rakovina Therapeutics Debentureholders Opt for Shares
PremiumCompany Announcements
Rakovina Therapeutics Debentureholders Opt for Shares
2M ago
RKV
Rakovina Therapeutics Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
PremiumPress Releases
Rakovina Therapeutics Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
2M ago
RKV
Rakovina Therapeutics Fuels R&D with $1.5M Placement
PremiumCompany Announcements
Rakovina Therapeutics Fuels R&D with $1.5M Placement
2M ago
RKV
Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
PremiumPress ReleasesRakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
2M ago
RKV
Rakovina Therapeutics Boosts AI-Driven Cancer Research
PremiumCompany Announcements
Rakovina Therapeutics Boosts AI-Driven Cancer Research
3M ago
RKV
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
PremiumPress Releases
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
3M ago
RKV
Rakovina Therapeutics Advances Cancer Fight Despite Losses
PremiumCompany Announcements
Rakovina Therapeutics Advances Cancer Fight Despite Losses
3M ago
RKV
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
3M ago
RKV
Rakovina Therapeutics Reveals Cancer Drug Breakthroughs
PremiumCompany Announcements
Rakovina Therapeutics Reveals Cancer Drug Breakthroughs
4M ago
RKV
Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today
PremiumPress Releases
Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today
4M ago
RKV
Rakovina Therapeutics Announces Webinar and Advisory Partnership
PremiumCompany AnnouncementsRakovina Therapeutics Announces Webinar and Advisory Partnership
4M ago
RKV
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024
PremiumPress Releases
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024
4M ago
RKV
Rakovina Therapeutics Embraces AI for Cancer Drug Development
PremiumCompany Announcements
Rakovina Therapeutics Embraces AI for Cancer Drug Development
4M ago
RKV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >